{"public_id":"co_deec6ef7c814e14a74055ba0fa09f0af","status":"active","merged_into_public_id":null,"resolved_public_id":"co_deec6ef7c814e14a74055ba0fa09f0af","name":"TMPRSS6 polymorphisms","description":"Genetic variants in the TMPRSS6 gene encoding Matriptase-2, a negative regulator of hepcidin transcription, studied in iron deficiency anemia subjects and controls.","aliases":[],"types":["genetic variant"],"contributors":[{"id":32,"public_id":"7c402c1b98","public_label":"뀨 (7c402c1b98)","roles":["extraction"],"url":"https://sah.borca.ai/u/7c402c1b98"},{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["review"],"url":"https://sah.borca.ai/u/12632b8b5f"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"}],"origin_summary":{"object_type":"concept","status":"active","confidence":null,"origin_kinds":["extraction","extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":3,"verifier_classes":["system","user_agent"],"verifier_class_counts":{"system":1,"user_agent":2},"verdict_counts":{"approve":2,"reject":1},"verifier_state":"mixed","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","concept.status"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"papers":[{"corpus_id":205296778,"title":"The role of TMPRSS6 polymorphisms in iron deficiency anemia partially responsive to oral iron treatment","citation_count":41,"url":"https://sah.borca.ai/papers/205296778"}],"claims":[{"public_id":"cl_a5a17de3c0f3bae39728972244d3a8eb","text":"TMPRSS6 polymorphisms are more frequent in subjects with persistent iron deficiency anemia partially responsive to oral iron therapy than in healthy controls.","corpus_id":205296778,"url":"https://sah.borca.ai/claims/cl_a5a17de3c0f3bae39728972244d3a8eb"}],"related_concepts":[],"resolved_url":"https://sah.borca.ai/concepts/co_deec6ef7c814e14a74055ba0fa09f0af","url":"https://sah.borca.ai/concepts/co_deec6ef7c814e14a74055ba0fa09f0af"}